190 related articles for article (PubMed ID: 1680799)
21. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
[TBL] [Abstract][Full Text] [Related]
22. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
23. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
24. Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes.
Lerman MI; Latif F; Glenn GM; Daniel LN; Brauch H; Hosoe S; Hampsch K; Delisio J; Orcutt ML; McBride OW
Hum Genet; 1991 Apr; 86(6):567-77. PubMed ID: 1673958
[TBL] [Abstract][Full Text] [Related]
25. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
26. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
27. Segregation and linkage analyses of von Hippel Lindau disease among 220 descendants from one kindred.
Go RC; Lamiell JM; Hsia YE; Yuen JW; Paik Y
Am J Hum Genet; 1984 Jan; 36(1):131-42. PubMed ID: 6582782
[TBL] [Abstract][Full Text] [Related]
28. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
30. The probe BMS1271 identifies a new polymorphic locus (D3S1207) and maps to 3p26-pter.
Heppell-Parton AC; Daly MC; Drabkin HA; Rabbitts PH
Cytogenet Cell Genet; 1993; 63(1):64-5. PubMed ID: 8095447
[TBL] [Abstract][Full Text] [Related]
31. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
32. Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.
Li H; Schmidt L; Duh FM; Wei MH; Latif F; Stackhouse T; Lerman MI; Zbar B; Tory K
Hum Mol Genet; 1993 Aug; 2(8):1326. PubMed ID: 8401520
[No Abstract] [Full Text] [Related]
33. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
[TBL] [Abstract][Full Text] [Related]
34. Specific genetic change in tumors associated with von Hippel-Lindau disease.
Tory K; Brauch H; Linehan M; Barba D; Oldfield E; Filling-Katz M; Seizinger B; Nakamura Y; White R; Marshall FF
J Natl Cancer Inst; 1989 Jul; 81(14):1097-101. PubMed ID: 2738940
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours.
Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER
Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274
[TBL] [Abstract][Full Text] [Related]
36. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic studies on three pheochromocytomas derived from patients with von Hippel-Lindau syndrome.
Kiechle-Schwarz M; Neumann HP; Decker HJ; Dietrich C; Wullich B; Schempp W
Hum Genet; 1989 May; 82(2):127-30. PubMed ID: 2722187
[TBL] [Abstract][Full Text] [Related]
38. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
[TBL] [Abstract][Full Text] [Related]
39. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
40. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
